Cates J, Chavez M, Laks H, Drinkwater D, Stevenson L, Kobashigawa J, Saunders K, Abedin M, Roslyn J
Department of Surgery, UCLA School of Medicine.
Am J Gastroenterol. 1991 Apr;86(4):412-6.
Cardiac transplantation has become an accepted treatment modality for end-stage cardiac failure. The gastrointestinal (GI) tract represents a potential source of posttransplant morbidity and mortality. To define the scope of this problem, records of all patients undergoing cardiac transplantation at UCLA between January 1984 and July 1989 were reviewed. In all, there were 120 patients (90 males and 30 females) with a mean age of 45.4 yr. Among them, there were 61 patients (51%) who developed a total of 112 posttransplant GI complications. Of the entire 120 patients, 41 (34%) developed minor complications and 20 (17%) sustained major GI morbidity. Eighteen patients (15%) underwent either endoscopy or surgical intervention. These data suggest that most cardiac transplant recipients will experience some form of GI complication, although most are minor and can be managed conservatively. However, when major, life-threatening complications occur, evaluation and intervention should proceed expeditiously. The gastroenterologist and GI surgeon should play complimentary roles in the care of these complicated patients.
心脏移植已成为终末期心力衰竭公认的治疗方式。胃肠道是移植后发病和死亡的潜在来源。为明确这一问题的范围,我们回顾了1984年1月至1989年7月在加州大学洛杉矶分校接受心脏移植的所有患者的记录。共有120例患者(90例男性和30例女性),平均年龄45.4岁。其中,61例患者(51%)共出现了112例移植后胃肠道并发症。在全部120例患者中,41例(34%)出现轻微并发症,20例(17%)发生严重胃肠道病变。18例患者(15%)接受了内镜检查或手术干预。这些数据表明,大多数心脏移植受者会经历某种形式的胃肠道并发症,尽管大多数为轻微并发症,可保守处理。然而,当发生严重的、危及生命的并发症时,应迅速进行评估和干预。胃肠病学家和胃肠外科医生在这些复杂患者的治疗中应发挥互补作用。